These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 33614973)

  • 1. Epigenetic mechanisms in hepatitis B virus-associated hepatocellular carcinoma.
    Andrisani O
    Hepatoma Res; 2021; 7():. PubMed ID: 33614973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of microRNA-210-3p in hepatitis B virus-related hepatocellular carcinoma.
    Morishita A; Fujita K; Iwama H; Chiyo T; Fujihara S; Oura K; Tadokoro T; Mimura S; Nomura T; Tani J; Yoneyama H; Kobayashi K; Kamada H; Guan Y; Nishiyama A; Okano K; Suzuki Y; Himoto T; Shimotohno K; Masaki T
    Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G401-G409. PubMed ID: 31905024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic repression of miR-132 expression by the hepatitis B virus x protein in hepatitis B virus-related hepatocellular carcinoma.
    Wei X; Tan C; Tang C; Ren G; Xiang T; Qiu Z; Liu R; Wu Z
    Cell Signal; 2013 May; 25(5):1037-43. PubMed ID: 23376496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The novel HBx mutation F30V correlates with hepatocellular carcinoma in vivo, reduces hepatitis B virus replicative efficiency and enhances anti-apoptotic activity of HBx N terminus in vitro.
    Salpini R; Surdo M; Cortese MF; Palumbo GA; Carioti L; Cappiello G; Spanò A; Trimoulet P; Fleury H; Vecchiet J; Pasquazzi C; Mirabelli C; Scutari R; Sacco A; Alkhatib M; Missale G; Francioso S; Sarmati L; Andreoni M; Angelico M; Ceccherini-Silberstein F; Levrero M; Perno CF; Belloni L; Svicher V
    Clin Microbiol Infect; 2019 Jul; 25(7):906.e1-906.e7. PubMed ID: 30472417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B virus X protein (HBx)-related long noncoding RNA (lncRNA) down-regulated expression by HBx (Dreh) inhibits hepatocellular carcinoma metastasis by targeting the intermediate filament protein vimentin.
    Huang JF; Guo YJ; Zhao CX; Yuan SX; Wang Y; Tang GN; Zhou WP; Sun SH
    Hepatology; 2013 May; 57(5):1882-92. PubMed ID: 23239537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic mechanism involved in the HBV/HCV-related hepatocellular carcinoma tumorigenesis.
    Rongrui L; Na H; Zongfang L; Fanpu J; Shiwen J
    Curr Pharm Des; 2014; 20(11):1715-25. PubMed ID: 23888939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic mechanisms in hepatocellular carcinoma: how environmental factors influence the epigenome.
    Herceg Z; Paliwal A
    Mutat Res; 2011; 727(3):55-61. PubMed ID: 21514401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulated long non-coding RNA DREH promotes cell proliferation in hepatitis B virus-associated hepatocellular carcinoma.
    Lv D; Wang Y; Zhang Y; Cui P; Xu Y
    Oncol Lett; 2017 Aug; 14(2):2025-2032. PubMed ID: 28789433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of HBV-induced hepatocellular carcinoma.
    Levrero M; Zucman-Rossi J
    J Hepatol; 2016 Apr; 64(1 Suppl):S84-S101. PubMed ID: 27084040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The direct and indirect roles of HBV in liver cancer: prospective markers for HCC screening and potential therapeutic targets.
    Ringelhan M; O'Connor T; Protzer U; Heikenwalder M
    J Pathol; 2015 Jan; 235(2):355-67. PubMed ID: 25196558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic silencing of SFRP1 and SFRP5 by hepatitis B virus X protein enhances hepatoma cell tumorigenicity through Wnt signaling pathway.
    Xie Q; Chen L; Shan X; Shan X; Tang J; Zhou F; Chen Q; Quan H; Nie D; Zhang W; Huang AL; Tang N
    Int J Cancer; 2014 Aug; 135(3):635-46. PubMed ID: 24374650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mapping the Heterogeneity of Histone Modifications on Hepatitis B Virus DNA Using Liver Needle Biopsies Obtained from Chronically Infected Patients.
    Flecken T; Meier MA; Skewes-Cox P; Barkan DT; Heim MH; Wieland SF; Holdorf MM
    J Virol; 2019 May; 93(9):. PubMed ID: 30787147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HBx represses RIZ1 expression by DNA methyltransferase 1 involvement in decreased miR-152 in hepatocellular carcinoma.
    Zhao Z; Hu Y; Shen X; Lao Y; Zhang L; Qiu X; Hu J; Gong P; Cui H; Lu S; Zheng Y; Zhou M; Fan H
    Oncol Rep; 2017 May; 37(5):2811-2818. PubMed ID: 28339081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Host Epigenetic Alterations and Hepatitis B Virus-Associated Hepatocellular Carcinoma.
    Zeisel MB; Guerrieri F; Levrero M
    J Clin Med; 2021 Apr; 10(8):. PubMed ID: 33923385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulated microRNA-152 induces aberrant DNA methylation in hepatitis B virus-related hepatocellular carcinoma by targeting DNA methyltransferase 1.
    Huang J; Wang Y; Guo Y; Sun S
    Hepatology; 2010 Jul; 52(1):60-70. PubMed ID: 20578129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular Pathogenesis of Hepatitis-B-virus-associated Hepatocellular Carcinoma.
    Park NH; Song IH; Chung YH
    Gut Liver; 2007 Dec; 1(2):101-17. PubMed ID: 20485626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct effects of hepatitis B virus-encoded proteins and chronic infection in liver cancer development.
    Ringelhan M; Heikenwalder M; Protzer U
    Dig Dis; 2013; 31(1):138-51. PubMed ID: 23797136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular mechanism of hepatitis B virus X protein function in hepatocarcinogenesis.
    Geng M; Xin X; Bi LQ; Zhou LT; Liu XH
    World J Gastroenterol; 2015 Oct; 21(38):10732-8. PubMed ID: 26478665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Epigenetic Control of Hepatitis B Virus Modulates the Outcome of Infection.
    Koumbi L; Karayiannis P
    Front Microbiol; 2015; 6():1491. PubMed ID: 26779147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Somatic mutations, viral integration and epigenetic modification in the evolution of hepatitis B virus-induced hepatocellular carcinoma.
    Ji X; Zhang Q; Du Y; Liu W; Li Z; Hou X; Cao G
    Curr Genomics; 2014 Dec; 15(6):469-80. PubMed ID: 25646075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.